REGN5458

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN5458, covering 2025-11-10 to 2025-11-10. Get the full timeline:

Most recent: Clinical Trial Update: Compassionate Use (CU) of REGN5458 for Patients With Relapsed or Refractory Multiple Myeloma (MM)